Home › Pharmacology › Peptidoglycan Synthesis (Bacterial Cell Wall)

Peptidoglycan Synthesis (Bacterial Cell Wall)

For medical students2 min readUpdated 2026-10-10

Peptidoglycan (murein) is a polymer that forms the protective structural mesh of the bacterial cell wall, located just outside the cytoplasmic membrane. Its synthesis involves intracellular building block formation, transmembrane transport, and final cross-linking into a rigid meshwork.

Cell wall backboneAlternating chains of NAG and NAM

Key amino acidDiaminopimelic acid (DAP) in Gram-negative bacteria

Penicillin targetTranspeptidases (penicillin-binding proteins)

Structure of Peptidoglycan

Peptidoglycan provides a rigid protective layer over the cytoplasmic membrane. In Gram-negative bacteria, it is additionally covered by an outer membrane composed of lipopolysaccharides, which serves as a permeability barrier against many antibiotics.

The polymer backbone consists of long chains alternating between two amino sugars:

N-acetylglucosamine (NAG);
N-acetylmuramic acid (NAM).

A short oligopeptide is attached to each NAM molecule. These peptide stems from adjacent polymer chains are cross-linked by peptide bridges, forming a robust three-dimensional mesh.

Step 1: Monomer Synthesis

The process begins in the cytoplasm and on the inner leaflet of the cell membrane. Glucose is converted into NAG and NAM. Then, a peptide chain is assembled onto the NAM molecule with the help of MurC, MurD, and MurE enzymes.

First, L-alanine and D-glutamate are sequentially added. The third amino acid depends on the bacterial species: in most Gram-positive bacteria, it is L-lysine, whereas in Gram-negative (and some Gram-positive) bacteria, it is diaminopimelic acid (DAP). Because DAP is absent in humans, it represents an attractive target for novel antibiotics.

Finally, a D-Ala-D-Ala dipeptide, synthesized from L-alanine by D-Ala-D-Ala ligase, is added to the chain.

After this, NAG is attached to the complex, and in Gram-positive bacteria, a connecting polypeptide—typically a pentaglycine bridge—is added to the third amino acid (lysine or DAP).

Step 2: Transport and Polymerization

The synthesized hydrophilic murein monomer cannot spontaneously cross the hydrophobic cytoplasmic membrane. Instead, a lipid carrier molecule called bacteroprenol (undecaprenyl phosphate) is utilized.

Bacteroprenol binds the monomer, transports it across the membrane to the outer surface, and integrates it into the growing polymer chain. After transglycosylase enzymes release the bacteroprenol, it is recycled back to the cytoplasm to pick up another building block.

Linear chain elongation (linking the NAM of the delivered monomer to the NAG of the existing polymer) is catalyzed by peptidoglycan glycosyltransferases.

Step 3: Transpeptidation (Cross-linking)

The final stage confers mechanical rigidity to the cell wall by cross-linking parallel peptidoglycan chains.

This process is catalyzed by transpeptidase enzymes. They bind to the terminal D-Ala-D-Ala dipeptide, cleave off the terminal D-alanine residue, and form a transient acyl-enzyme complex with the peptidoglycan. Next, the free amino group of a neighboring peptide chain attacks this complex, forming a covalent cross-link.

Transpeptidases are the primary targets of $\beta$-lactam antibiotics (e.g., benzylpenicillin), which is why these enzymes are known as penicillin-binding proteins (PBPs).

Mnemonic

Remember the backbone: "NAM and NAG build the scaffold."

Frequently asked questions

Which antibiotics inhibit the cytoplasmic stage of peptidoglycan monomer synthesis?

Early stages of cell wall synthesis are targeted by inhibitors that disrupt murein monomer building blocks in the cytoplasm.

Fosfomycin — irreversibly blocks the enzymatic condensation of UDP-N-acetylglucosamine, preventing murein monomer formation.
Fosmidomycin — disrupts early stages of cell wall biosynthesis.

Which antibiotic blocks monomer transport by disrupting the bacteroprenol cycle?

Transport of murein monomers across the membrane is inhibited by the peptide antibiotic bacitracin, which targets the lipid carrier.

Bacitracin — blocks the dephosphorylation (regeneration) of bacteroprenol pyrophosphate, causing it to lose its carrier function and halting cell wall synthesis.

Which antibiotic classes inhibit the transpeptidation step of cell wall synthesis?

Polymer cross-linking (transpeptidation) is inhibited by drugs that bind to penicillin-binding proteins and suppress transpeptidase activity.

Carbapenems — bind to specific penicillin-binding proteins and inhibit transpeptidases, preventing peptidoglycan cross-linking.

How does the cell wall structure of Gram-negative bacteria differ from Gram-positive bacteria?

Gram-positive and Gram-negative cell walls differ significantly in peptidoglycan layer thickness and the presence of additional protective structures.

Feature	Gram-positive	Gram-negative
Cell wall thickness	20–60 nm	10–20 nm
Peptidoglycan dry weight	40–90%	5–10%
Teichoic acids	+	-
Periplasmic space	-	+
Outer membrane	-	+
Gram stain color	Purple/Violet	Pink/Red

What are penicillin-binding proteins (PBPs) and why are they called that?

They are transpeptidases—enzymes that catalyze the cross-linking of peptidoglycan chains. Beta-lactam antibiotics (penicillins) bind to and block their activity, hence the name penicillin-binding proteins.

What is the function of bacteroprenol?

It acts as a hydrophobic lipid carrier. Monomer components are hydrophilic and cannot independently cross the hydrophobic cell membrane.

How does the third amino acid of the peptide chain differ among bacteria?

Most Gram-positive bacteria use L-lysine, whereas Gram-negative bacteria use diaminopimelic acid (DAP).

Go deeper

Mechanism of action of beta-lactam antibiotics
Structure of the Gram-negative outer membrane
Monomer biosynthesis enzymes (MurA-MurF)
The bacteroprenol cycle and associated pharmacological agents